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5,437,684 8/1995 Calabrese et al. . However, open heart Surgery includes a myriad of disad Vantages. Open heart Surgery typically includes a great deal of postoperative pain. The pain is normally encountered because conventional open heart Surgery requires that the Sternum be cracked open, which is quite painful. Also, open heart Surgery typically involves bypassing the occluded vessel, which, in turn, involves harvesting a vein from another part of the body for use as the bypass graft. One common Source for the bypass graft is the Saphenous vein which is removed from the leg. Harvesting the Saphenous vein requires the Surgeon to cut and peel the skin back from an area of the leg which is approximately 18 inches long and which extends upward to the groin area. This can be very traumatic and painful. Further, open heart Surgery requires quite a lengthy recovery period which involves an increased hospital stay, and, consequently, greater expense.
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Other than the pain and more lengthy hospital Stay, open heart Surgery involves other disadvantages as well. For example, during open heart Surgery, it is common to cool the heart to a point where it stops. The blood from the remainder of the vasculature is then pumped through a pulmonary and cardiac bypass System. Any time the heart is stopped, there is a danger of encountering difficulty in restarting the heart (which is typically accomplished by warming the heart and massaging it). Further, even if the heart is restarted, it Sometimes does not return to a correct rhythm. Also, open heart Surgery can require the use of a device known as a left ventricular assist device (LVAD) to Supplementarily pump blood to relieve the burden on the heart. This allows the heart to heal. 2 A significant reason that the heart is typically stopped during open heart Surgery is that, if it were not stopped, the Surgeon would be working in a dynamic environment. In Such an environment, the target vessels and tissue to be treated are moving. Further, a System must be employed in Such an environment to Stop bleeding. Clinical Studies indicate that, when blood flow is stopped using clamping devices and blood flow is diverted to a cardiac bypass System, a Statistically significant instance of neurological problems caused by blood clotting results. The use of mechanical clamps to Stop blood flow, and the use of a mechanical bypass System, results in an approximate Six percent instance of neurological problems, Such as Stroke, memory failure, etc.
Given the difficulties of the techniques discussed above, another approach has been developed which does not require Stoppage of the heart or an open chest during execution. This approach is to perform a bypass using a minimally invasive technique by entering the upper chest cavity, through a hole between ribs under Visual observation. Such a technique is often referred to as minimally invasive direct coronary artery bypass (MIDCAB) (where the heart is not stopped) or heart port (where the heart is stopped), or if performed below the diaphragm, Simply as laproscopic Surgery. Such a System which is used to perform a bypass is disclosed in the 
SUMMARY OF THE INVENTION
In order to bypass a restriction in a parent vessel, a first Site in a branch vessel branching from the aorta is accessed intraluminally. An occlusion which may be permanent or temporary is optionally formed at the first Site, and an aperture is formed in the branching vessel, intraluminally, proximal of the first site. An aperture is formed in the parent vessel distal of the restriction, and a conduit is provided to form a lumen which communicates between the branching vessel proximal of the occlusion, and the parent vessel distal of the restriction.
In one preferred embodiment, the lumen communicating between the branching vessel and the parent vessel com prises a graft introduced intraluminally into the branching vessel and connected between the branching vessel and the parent vessel. In another preferred embodiment, the branch ing vessel is Severed proximal of the first site and the Severed end of the branching vessel is attached to the parent vessel Such that the branching vessel, itself, forms the conduit between a proximal portion of the branching vessel and the parent vessel distal of the restriction. is shown coming from the ascending aorta, this is primarily for purposes of clarity. It will be understood that most branching vessels originate from the aortic arch, or the descending aorta, but the present description will proceed with respect to branching vessel 20, for the purposes of clarity only. It should be noted that, the term branching vessel as used in the present description contemplates any vessel which branches, directly or indirectly, from the aorta, and which can be used to supply blood flow as described herein, without detrimentally affecting another portion of the body. It will also be noted that the IMA 19 is a preferred branching vessel for use in accordance with the present invention because the blood flow through the IMA 19 is provided to a region of the body which also has collateral or backup flow. Therefore, if blood flow from the IMA 19 is removed, the region served by the IMA will obtain sufficient blood flow from other sources. However, the remainder of the present description will proceed with respect to branch ing vessel 20 which will be understood to be any suitable branching vessel in the vasculature. In one preferred embodiment, occlusion device 30 com prises an elongate portion 34 which Supports a heated balloon 36. Heated balloon 36 is advanced to site 32 and is then activated so that it cauterizes vessel 20 at site 32, thereby creating a total occlusion 38 at site 32.
In another preferred embodiment, occlusion device 30 is Simply a delivery catheter which is used to deliver coils, collagen, or another suitable material to site 32 in vessel 20 to create occlusion 38.
It should be noted that occlusion 38 at site 32 is not required and, if utilized, may be either a permanent or temporary occlusion. In any case, after occlusion 38 has been formed, occlusion device 30 is withdrawn from system 10, through guide catheter 24. The distal tip 46, or an cuter periphery of expandable member 44, is preferably provided with a cutting edge, or cutting blade which can be rotated by manipulation of the physician, in order to cut through the walls of vessel 20. Expandable member 44 can preferably be retained in the expanded position during the cutting procedure. This Serves to occlude vessel 20 after it has been severed.
In addition, it should be noted that cutting device 40 can Where branching vessel 20 is one such as the IMA which is embedded in tissue, it must be separated from that tissue prior to being steered toward artery 16. This can be done using a Suitable dissection System, Such as using known devices to perform the dissection via a thoracic approach. In another preferred embodiment, location of various items within the vasculature is accomplished using a trian gulation and coordinate mapping System. In that embodiment, a radio frequency (RF) emitter is placed in the heart, or in the vasculature near the heart. The RF emitter is preferably placed on a catheter or another device, the placement of which must be guided. A number of reference electrodes (or receivers) are placed on the outside of the body at various points on the chest and back. In the preferred embodiment, three reference receivers are placed on the exterior of the body, two on the chest on opposite Sides of the heart and one on the back. The three receivers are used to triangulate on the RF transmitter located on the device within the vasculature. Three dimensional modeling can be used, along with known motion and analysis techniques to determine the placement and motion of the RF transmitter within the vasculature. Such a System can be used to obtain true position and the relative positions of different objects in the vasculature. Of course, a higher frequency Signal could also be used, and a similar device could be used in which magnetic Sensing devices are employed.
If In the preferred embodiment, the body of graft 66 is preferably either a biologically compatible, artificial graft (Such as PTFE material), or a section of a human vein, Such as a Saphenous vein graft.
FIGS. 7A and 7B illustrate in greater detail the manner in which graft 66 is deployed within vessel 20 and native vessel 16. Prior to performing the method illustrated herein the patient may be placed on full cardiopulmonary bypass and heart 12 is stopped. Alternatively, the heart need not be Once in place, balloons 80 and 82 are expanded. Balloon 80 is first inflated to expand stent 72 to low pressure, and distal occlusion balloon 65, which is attached to wire 50, is deflated and removed. Balloons 80 and 82 are then expanded to such a degree that stents 72 and 74 expand radially outwardly So that the exterior of the Stents achieves an outer diameter which closely approximates the inner diameter of the vessel within which it is deployed. This causes a frictional fit between the outer Surface of the stents 72 and 74 (or the ends of graft 66) and the inner surface of the lumens within which they are deployed. In addition, a Suitable adhesive or glue can be applied to the Stents 72 and 74 to further facilitate anastomosis in the vessels in which they are deployed.
It should, however, be noted that deployment of stent 66 can be performed in other manners. For example, balloons 80 and 82 can be placed within the interiors of stents 72 and 74, respectively, prior to insertion of graft 66 into the vascular system 10. In that case, balloons 80 and 82 would preferably form an assembly insertable with wire 68 during the procedure. Alternatively, Stent 66 can be deployed using only a single inflatable member. In that case, the Single inflatable member would first be placed within the interior of one of stents 72 and 74 in the deflated position and then inflated to Secure the respective Stent in the appropriate vessel. The balloon is then moved to reside within the other stent 72 or 74 where it is inflated to deploy that stent in the appropriate vessel as well.
FIGS. 9A and 9B illustrate yet another aspect of the present invention. For the purposes of illustration of this aspect of the invention, a distal portion 92 of graft 66 is deployed within vessel 16, distal of occlusion 22. In the embodiment shown in FIGS. 9A and 9B, distal portion 92 of graft 66 includes end 76 of the graft 66, along with stent 72. The outer diameter of distal portion 92 of graft 66 preferably includes sheath 94. Sheath 94 preferably has an inner radial surface 96 which is impermeable to fluid flow, and an outer FIG. 12 illustrates a stent graft 144 which is similar to Stent graft 120, and is employed in a similar manner. However, stent graft 144 is a doubly bifurcated stent graft which not only includes balloons 128 and 130 in a bifurcated proximal tubular end 126, but stent graft 144 also includes stents 146 and 148 which form a distally bifurcated end 150.
All four stents 128, 130, 146 and 148 are used to anchorstent graft 144 in place.
It has also been found that Some grafts tend to degenerate after approximately 10 years of use. Therefore, in accor dance with one additional aspect of the present invention, the grafts are structurally reinforced with a mechanical Outer shell to Strengthen the graft. In one embodiment, the mechanical outer shell is a sheath which is formed of, for example, woven Dacron, Gortex, or polyester. The sheath is preferably configured So that the vein graft can be passed through the sheath prior to deployment of the graft in the vasculature. Then, the reinforcing sheath is pulled at its In another embodiment, the vein graft is wrapped with a material which Strengthens the vein graft. In one embodiment, the vein graft is wrapped with, for example, hook and loop tape (such as Velcro tape) wherein the hooks on the hook and loop tape engage the adventitious layer of the vein graft. The hook and loop tape can be any Suitable fabric backed microhoop strip which has hooks suitable for engaging the adventitious layer on the exterior of the vessel wall. Ultrasound is preferably used to measure the size of the vein and to adjust the tension in the reinforcement layer Such that the interior of the reinforcement layer closely approxi mates the exterior dimension of the vein graft.
It should also be noted that, in one preferred embodiment, extra working Space can be created in the chest cavity in order to facilitate manipulation of the various devices described herein. According to one aspect of the present invention, a needle or cutting tip catheter is used to form an incision in the branching vessel, as described above. Then, one of a number of things is used to create additional working Space. For instance, a balloon may preferably be advanced through the hole in the branching vessel, expanded in the interstitial spaceS proximate thereto to create addi tional working Space. Also, a bioabsorbable, or removable, material can be optionally injected through the aperture in the branching vessel to expand the area thereabout and create additional working Space. These features are prefer ably used in order to replace CO2 injection which is com monly used in, for instance, laproscopic Surgery.
Thus, it can be seen that the present invention involves a System by which coronary artery bypass procedures can be executed Substantially percutaneously and transluminally. This Serves to Significantly reduce the disadvantages asso ciated with prior treatment techniques. In the embodiment in which a branching vessel is used to form the conduit providing blood flow, as opposed to a graft, the present invention eliminates half of the intraluminal connections required in a typical graft procedure. In other words, Since the branching vessel is only Severed in one place, only one end of the branching vessel needs to be connected to the parent vessel. This requires only one intraluminal connec tion (or anastomosis) as opposed to two which are required where an anastomosis must be formed between a graft and both the conduit supplying the blood flow, and the artery receiving the blood flow. Further, Since the present invention utilizes a branching vessel, it is relatively easy to occlude blood flow in the relevant vasculature (i.e., in the branching vasculature and the occluded vasculature). This occlusion is relatively easy as opposed to the necessity of occluding blood flow throughout the entire aorta in systems which provide a graft directly from the aorta.
Although the present invention has been described with reference to preferred embodiments, workerS Skilled in the art will recognize that changes may be made in form and detail without departing from the Spirit and Scope of the invention.
What is claimed is:
1. A method of percutaneously bypassing an incomplete occlusion in a restricted artery of a mammal having an aorta and a branching vessel branching from the aorta, the method comprising:
intraluminally accessing a first Site in the branching vessel;
intraluminally forming an aperture in the branching vessel at the first site; intraluminally forming a total occlusion in the restricted artery;
forming an aperture in the restricted artery distal of both the incomplete occlusion and the total occlusion; and providing a conduit to form a lumen communicating through the aperture in the branching vessel with a lumen in the branching vessel proximal of the first site and through the aperture in the restricted artery with a lumen of the restricted artery distal of the incomplete occlusion and the total occlusion.
2. The method of claim 1 wherein intraluminally forming an aperture in the branching vessel comprises:
intraluminally Severing the branching vessel at the first Site to form a Severed end.
3. The method of claim 2 wherein providing a conduit comprises:
attaching a region of the branching vessel proximate the Severed end to a region of the restricted artery proxi mate the aperture Such that a lumen in the branching vessel communicates with a lumen in the restricted artery.
4. The method of claim3 wherein attaching a region of the branching vessel comprises:
inserting the Severed end of the branching vessel through the aperture in the restricted artery into the lumen of the restricted artery; and connecting the Severed end to the restricted artery. 5. The method of claim 4 wherein connecting the severed end comprises: deploying a Stent in the restricted artery to attach the Severed end to the restricted artery. 6. The method of claim 1 and further comprising: prior to forming an aperture in the branching vessel, forming an occlusion in the branching vessel distal of the first site.
7. The method of claim 1 and further comprising: prior to forming the aperture in the branching vessel, temporarily occluding the branching vessel proximal of a region in the branching vessel where the aperture is to be formed.
8. The method of claim 7 wherein temporarily occluding comprises:
advancing an expandable member through the branching vessel to the region proximal of the aperture in the branching vessel; and expanding the expandable member to occlude the branch ing vessel. 9. The method of claim 1 wherein providing a conduit comprises:
placing a first emitter in the region of the restricted artery distal of both the incomplete occlusion and the total occlusion and a Second emitter in an end of the conduit, the first and Second emitters emitting location Signals, Sensing the location Signals and providing an operator perceptible output indicative of the location of the end 11. The method of claim 10 wherein attaching a region of the branching vessel comprises:
inserting the Severed end of the branching vessel through the aperture in the restricted artery into the lumen of the restricted artery; and connecting the Severed end to the restricted artery. 12. The method of claim 11 wherein connecting the Severed end comprises: deploying a stent in the restricted artery to attach the Severed end to the restricted artery.
13. The method of claim 10 wherein the restriction in the parent vessel is an incomplete occlusion, and further com prising: prior to forming an aperture in the restricted artery, forming a total occlusion in the restricted artery proxi mal of a region where the aperture is to be formed. 14. The method of claim 10 wherein attaching a region of the branching vessel proximate the Severed end comprises: placing a first emitter in the region of the restricted artery distal of the restriction and a Second emitter in the branching vessel proximate the Severed end, the first and Second emitters emitting location Signals, Sensing the location Signals and providing an operator perceptible output indicative of the location of the Severed end relative to the region of the restricted artery distal of the restriction; and positioning the Severed end proximate a region of the restricted artery distal of the restriction based on the operator perceptible output.
